Q5
LONG ANSWER
10M
★ High-yield
Describe Bacillus anthracis with its morphology, toxin, clinical forms and diagnosis. Add a note on other aerobic spore-bearers.
Bacillus Anthracis — Morphology
- Large, gram-positive, aerobic, spore-bearing bacillus with square-cut (truncated) ends, arranged in long chains giving a "bamboo stick" appearance
- Non-motile — which distinguishes it from almost all other Bacillus species, which are motile
- The only bacterium with a polypeptide capsule, made of poly-D-glutamic acid; being D-amino acid it resists proteolysis and is poorly immunogenic. The capsule is formed IN tissue (and in culture with bicarbonate and carbon dioxide), not on ordinary media
- Spores are central, oval and non-bulging, formed only in the presence of oxygen — so they are not formed in the living host, but appear once the carcass is opened. This is why anthrax carcasses must not be opened or skinned, and are burned or buried deeply
| Test or appearance | Finding |
|---|---|
| McFADYEAN reaction | Polychrome methylene blue stain of blood or tissue shows blue bacilli surrounded by a pink (amorphous) capsule — a rapid presumptive diagnosis |
| Colony morphology | "MEDUSA head" or "curled hair lock" colonies with wavy edges on nutrient agar; non-haemolytic on blood agar |
| Gelatin stab | "inverted FIR tree" appearance with slow liquefaction |
| String OF pearls test | On agar with low-dose penicillin the bacilli become large spherical forms in chains — a useful identification test |
| ASCOLI thermoprecipitin test | A ring precipitation test detecting anthrax antigen in decomposed animal material, where culture has failed |
| Bacteriophage | Susceptible to gamma phage — a confirmatory test |
Anthrax Toxin and Pathogenesis
- Three components, each harmless alone — protective antigen (PA), which binds the cell and forms the channel; oedema factor (EF), a calmodulin-dependent adenylate cyclase that raises cAMP and causes massive oedema; and lethal factor (LF), a protease that cleaves map kinase kinases, killing macrophages and releasing cytokines
- PA + EF = oedema toxin; PA + LF = lethal toxin. Protective antigen is essential to both, which is why it is the component used in the vaccine — antibody to it blocks delivery of the other two
- Both toxin and capsule are plasmid-encoded (pXO1 and pXO2); loss of either plasmid attenuates the organism, which is the basis of the Sterne vaccine strain
CLINICAL PEARL
Protective antigen is called protective because vaccinating against it works, not because it protects the bacterium. It is the delivery mechanism: neither oedema factor nor lethal factor can enter a cell without it. Antibody to protective antigen therefore neutralises both toxins at once, which is a far more efficient target than either enzyme — and a good general lesson in choosing a vaccine antigen.
Clinical Forms of Anthrax
| Form | Route | Features and mortality |
|---|---|---|
| Cutaneous (about 95%) | Inoculation through broken skin, in those handling animals, hides, wool or bone meal | A papule becomes a vesicle then a painless, black, necrotic eschar ("malignant pustule") with marked surrounding non-pitting oedema and lymphadenopathy. Painlessness is the characteristic feature. Mortality under 20% untreated, under 1% treated |
| Pulmonary ("woolsorter'S disease") | Inhalation of spores | A biphasic illness — a flu-like prodrome, then abrupt deterioration with severe dyspnoea, shock and haemorrhagic mediastinitis (widened mediastinum on radiograph, without typical pneumonia). Mortality very high even with treatment |
| Intestinal | Ingestion of contaminated meat | Severe gastroenteritis with bloody diarrhoea, ascites and shock; high mortality |
| Injectional | Contaminated heroin | Severe soft tissue infection in drug users |
| Meningeal | Haematogenous spread from any form | Haemorrhagic meningitis ("cardinal's cap"); almost invariably fatal |
- Treatment — ciprofloxacin or doxycycline (penicillin is effective against sensitive strains but resistance has been engineered), with combination therapy and antitoxin (raxibacumab) in systemic disease; the cutaneous lesion is not excised, since surgery may disseminate it
- Anthrax is a recognised bioterrorism agent, because spores are stable, easily disseminated and cause high mortality by inhalation; this is why inhalational anthrax in an unexplained setting is treated as a public health emergency
Other Aerobic Spore-bearers
| Organism | Disease and features |
|---|---|
| Bacillus cereus | Two distinct food poisoning syndromes: an emetic form from a heat-stable preformed toxin with a short incubation of 1 to 5 hours, classically after reheated fried rice; and a diarrhoeal form from a heat-labile enterotoxin with a longer incubation of 8 to 16 hours. Also causes post-traumatic endophthalmitis and line infection |
| Bacillus subtilis | A common laboratory and air contaminant; its spores are used as a biological indicator for hot air oven and ethylene oxide sterilisation |
| Geobacillus stearothermophilus | Highly heat-resistant spores used as the biological indicator for autoclave control |
| Anthracoid bacilli | Non-pathogenic Bacillus species resembling B. Anthracis but motile, haemolytic, non-capsulated and gamma-phage resistant — the differentiation that matters in the laboratory |
Laboratory Diagnosis and Prevention of Anthrax
- Specimens — vesicle fluid or material from the eschar edge, blood, sputum, cerebrospinal fluid, and tissue or animal material
- Handle at BSL-3 where inhalational anthrax is suspected, and warn the laboratory, since anthrax is a recognised cause of laboratory-acquired infection
- Direct examination — Gram stain showing large square-ended bacilli in chains, and the McFADYEAN capsule reaction
- Culture on blood and nutrient agar, with Medusa head colonies, non-motility, non-haemolysis, gamma-phage susceptibility and the string of pearls test
- Serology and PCR for toxin and capsule genes; the ASCOLI test where material is decomposed
- Prevention — animal vaccination (the Sterne live attenuated non-capsulated strain) is the key control measure; safe carcass disposal by burning or deep burial with lime; protective equipment for those handling hides and wool; and human vaccination with protective antigen for high-risk occupational groups and military personnel. Post-exposure prophylaxis with ciprofloxacin for 60 days, because inhaled spores may germinate late
Applied Aspects
- Do not open or skin a carcass suspected of anthrax; spores form only on exposure to oxygen, and opening the animal contaminates the soil for decades. Carcasses are burned or buried deeply with lime
- Anthrax is a notifiable and occupational disease in India, occurring in agricultural and animal-handling communities in several states; control depends on animal vaccination and safe carcass disposal rather than on human treatment
- Suspect anthrax in a painless black eschar with disproportionate oedema in someone with animal contact — the painlessness distinguishes it from staphylococcal and streptococcal lesions
- Reheated rice is the classic vehicle for Bacillus cereus emetic disease; the spores survive boiling, germinate as the rice cools slowly, and the toxin is not destroyed by reheating — so cooked rice must be cooled rapidly and refrigerated
- Bacillus species in a blood culture are usually contaminants, but should not be dismissed automatically in a neutropenic patient or one with an intravascular device
- Spore-formers define sterilisation standards — the biological indicators for every sterilising process are Bacillus spores, because they are the most resistant form of life to that process
- Distinguish B. Anthracis from the anthracoid bacilli carefully; the latter are common contaminants, and the practical differences are motility, haemolysis, capsule and gamma-phage susceptibility
- Cutaneous anthrax is not excised, since surgery risks dissemination; it is treated with antibiotics and the eschar allowed to separate
- Post-exposure prophylaxis after inhalational exposure runs for 60 days, because spores may lie dormant in the mediastinal nodes and germinate long after exposure — a far longer course than intuition suggests
- Occupational health matters more than clinical medicine here; vaccinating livestock, disposing of carcasses safely and protecting hide and wool workers prevents almost all human anthrax
- Warn the laboratory when anthrax is suspected; several documented laboratory-acquired infections have followed routine handling of an unlabelled specimen on an open bench
- Inhalational anthrax presents as a widened mediastinum without pneumonia, which is an unusual radiological combination and should raise the possibility immediately
- An unexplained case of inhalational anthrax is a public health emergency and must be notified at once, since the natural form is now vanishingly rare
- Cook rice in the quantity needed and refrigerate promptly; the Bacillus cereus emetic toxin is not destroyed by reheating, so the prevention lies entirely in rapid cooling rather than in the final heating
- Anthrax spores survive in soil for decades, so land where an infected animal died remains hazardous long after any living memory of the event
- Bacillus cereus also causes severe eye infection after penetrating trauma, progressing to loss of the eye within a day, so a contaminated ocular injury must be treated urgently rather than observed
All questions in Gram-positive Cocci & Bacilli
- Q1Classify staphylococci. Describe the virulence factors, toxin-mediated diseases and laboratory diagnosis of Staphylococcus aureus. ★
- Q2Classify streptococci. Describe the virulence factors, diseases and non-suppurative sequelae of Streptococcus pyogenes. ★
- Q3Describe Corynebacterium diphtheriae with its morphology, toxin, clinical features, laboratory diagnosis and prevention. ★
- Q4Describe Clostridium tetani and Clostridium perfringens with their toxins, clinical features and management. ★
- Q5Describe Bacillus anthracis with its morphology, toxin, clinical forms and diagnosis. Add a note on other aerobic spore-bearers. ★
- SN1Describe Streptococcus pneumoniae with its identification, diseases and prevention. ★
- SN2Describe MRSA with its mechanism of resistance, detection, treatment and control. ★
- SN3Describe Clostridium botulinum and botulism with its clinical forms and management. ★
- SN4Describe Clostridioides difficile infection with its pathogenesis, diagnosis and management. ★
- SN5Describe the enterococci with their intrinsic resistance, infections and VRE. ★
- SN6Describe Listeria monocytogenes with its pathogenesis, clinical disease and treatment. ★
- SN7Compare Actinomyces and Nocardia. Add a note on mycetoma.